Literature DB >> 12689706

An interlaboratory comparison for the detection of Mycoplasma pneumoniae in respiratory samples by the polymerase chain reaction.

D Ursi1, M Ieven, G T Noordhoek, M Ritzler, H Zandleven, M Altwegg.   

Abstract

A panel of 78 respiratory samples collected from 43 patients was analyzed in three different Centers for the presence of Mycoplasma pneumoniae DNA by polymerase chain reaction (PCR). One Center collected the samples and extracted the DNA by two different methods. DNA extracted according to the first method was amplified using primers targetting the 16 S rRNA gene. DNA extracted according to the second method was amplified using the same primers in a semi-nested format and was sent to the two other Centers. The latter Centers both used the same primers targetting the P1 gene but with a different detection format. Thirty-nine samples (50%) from 19 patients were positive by at least two PCR assays. None of the laboratories were free of false positive or false negative PCR results. Calculated specificities of the individual PCR assays ranged from 97.4% to 87.2% and sensitivities ranged from 97.4% to 89.2%. Complement fixation was done on sera of 33 patients. The calculated specificity and sensitivity of serology was 100% and 58.8%, respectively. Several aspects concerning false positive and false negative results with PCR are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689706     DOI: 10.1016/s0167-7012(02)00230-0

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  9 in total

Review 1.  Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections.

Authors:  K Loens; D Ursi; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Evaluation of five commercial real-time PCR assays for detection of Mycoplasma pneumoniae in respiratory tract specimens.

Authors:  A Touati; A Benard; A Ben Hassen; C M Bébéar; S Pereyre
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

Review 3.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

4.  Rapid mycoplasma culture for the early diagnosis of Mycoplasma pneumoniae infection.

Authors:  Ling-di Ma; Baojin Chen; Yanfen Dong; Jing Fan; Lei Xia; Shi-zhong Wang; Qian Liu; Lijia Jiang
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 5.  Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology.

Authors:  Ken B Waites; Li Xiao; Vanya Paralanov; Rose M Viscardi; John I Glass
Journal:  J Mol Diagn       Date:  2012-07-20       Impact factor: 5.568

6.  The role of Mycoplasma in upper respiratory infections.

Authors:  Ken B Waites; T Prescott Atkinson
Journal:  Curr Infect Dis Rep       Date:  2009-05       Impact factor: 3.725

7.  Laboratory diagnosis of Mycoplasma pneumoniae respiratory tract infections in children.

Authors:  E Souliou; M Almasri; A Papa; A Theodoridou; E Diza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06-07       Impact factor: 5.103

Review 8.  Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods.

Authors:  K Loens; H Goossens; M Ieven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-06       Impact factor: 3.267

9.  Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study.

Authors:  Emiel B M Spuesens; Pieter L A Fraaij; Eline G Visser; Theo Hoogenboezem; Wim C J Hop; Léon N A van Adrichem; Frank Weber; Henriette A Moll; Berth Broekman; Marjolein Y Berger; Tineke van Rijsoort-Vos; Alex van Belkum; Martin Schutten; Suzan D Pas; Albert D M E Osterhaus; Nico G Hartwig; Cornelis Vink; Annemarie M C van Rossum
Journal:  PLoS Med       Date:  2013-05-14       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.